No Detail Found!

Demographics and Outcome in Paediatric Non-hodgkin Lymphoma: Single Centre Experience at the Children Hospital, Lahore, Pakistan.

Author(s)
Mahwish Faizan Department of Pediatric Hematology / Oncology, The Children Hospital and Institute of Child Health, Lahore, Pakistan
Saadia Anwar Department of Pediatric Hematology / Oncology, The Children Hospital and Institute of Child Health, Lahore, Pakistan
Safia Khan Department of Pediatric Hematology / Oncology, The Children Hospital and Institute of Child Health, Lahore, Pakistan
Abstract
Objective: To describe the patient demographics and outcome analysis in paediatric non-Hodgkin lymphoma (NHL) patients. Study Design: An observational study. Place and Duration of Study: The Hematology/Oncology Unit of The Children's Hospital and Institute of Child Health, Lahore, from January 2012 till December 2014. Methodology: Demographics including age, gender, histopathology, stage and outcome data, in biopsy proven NHL patients were analyzed. Burkitts/B Cell and Diffuse Large B Cell lymphoma patients were treated with MCP 842 Protocol while T/B-cell lymphoblastic lymphoma (LL) patients were treated with EURO-LB 02 protocol. Results: Ninety-one patients were treated during the study period at CHL. Data was insufficient in 18 patients, so they were excluded from the study. Patients included were 73. Males were 53 (72.6%). Thirty-seven (50.7%) were 5-10 years of age, and 22 (30.1%) 10-16 years old. Abdominal mass was the commonest presentation seen in 32 (43.8%), lymphadenopathy in 27 (37%), intussusception in 5 (6.8%), while intestinal obstruction, obstructive uropathy, nasopharyngeal mass, gastric mass, primary bone lymphoma, pericardial effusion, jaw swelling, cheek swelling and paraspinal mass present in one (1%) each. Histopathological subtypes consist of Burkitt's lymphoma (BL) in 32 (43.8%), B cell NHL in 10 (13.7%), lymphoblastic lymphoma (LL) in 26 (35.6%), diffuse large B cell lymphoma (DLBCL) in 2 (2.8%), and anaplastic large cell lymphoma (ALCL) in 1 (1.4%). Sixty-seven (91%) presented in stage III, and six (8.4%) in stage IV. Forty-eight (65.8%) patients had completed treatment and are well to date, 16 (21.9%) died, 5 (6.8%) left against medical advice (LAMA), and 4 (5.5%) patients relapsed. Conclusion: Burkitt's lymphoma was the commonest type of NHL seen in this cohort that predominantly presented with an abdominal mass. Children usually presented in advanced stage with delayed diagnosis. Better supportive care can improve the prognosis significantly. Training of pediatricians is equally important along with increasing parental/family knowledge about the disease symptoms so that they can seek early medical care, and earlier diagnosis is possible.
Publication Details
Page(s) 48-51
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 1, Year: 2018

Request the full text from PASTIC

References
KaatschP, 2010.Epidemiology of Childhood cancer,Cancer Treat Rev 36 277 -85
WardE,De SantisC,RobbinsA, 2014.,Ca Cancer J Clin 64 83 -103
SwerdlowSH,CampoE,PileriSA, 2016.The 2016 revision of the World Health Organization classification of lymphoid neoplasms,Blood 127 2375 -90
PulteD,GondosA,BrennerH., 2008.Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States,,J Natl Cancer Inst 18 1301 -9
Steliarova-FoucherE,StillerC, 2005.International classification of childhood cancer,Cancer 103 1457 -67
RosolenA,PerkinsSL,PinkertonR,GuiilermanP,SanflundJT, 2015.Revised international pediatric non-Hodgkin lymphoma staging system,J Clin Oncol 33 2112 -8
MbulaiteyeSM,AndersonWF,FerlayJ,BhatiaK,ChangC,RosenbergPS, 2012.Pediatric, elderly, and emerging adultonset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa,Am J Hematol 87 573 -8
SheriefLM,ElsafyUR,AbdelhalekER,KamalNM,YoussefDM, 2015.Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt,Mol clin Oncol 3 139 -44
ManipadamMT,NairS,ViswabandyaA,MathewL,SrivastavaA,ChandyM, 2011.Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India,World J Pediatr 7 318 -25
FadooZ,BelgaumiA,MatloobA,IqbalA,NaqviA, 2010.Pediatric lymphoma: A 10-year experience at a tertiary care hospital in,Pakistan J Pediatr Hematol Oncol 32 14 -18
GrossTG,PerkinsSL,PizzoPA,PoplackDG, 2011.Malignant non-Hodgkin's lymphoma in children,Principles and practice of pediatric oncology. 6th. Lippincott Williams: Philadelphia: 663 -82
ManzellaA,BorbafilhoP,D'IppolitoG,FariasM., 2013.Abdominal manifestations of lymphoma: Spectrum of imaging features,ISRN Radiol 12 1 -11
HuangH,LiangZL,ZegH,XuHY,WuY,ZengST, 2015.Clinicopathological study of sporadic Burkitt lymphoma in children,Chin Med J 128 510 -14
OremJ,KatongoleEM,LambertB,SanjoseDS,WeiderpassbE.,Burkitts, 2007.Lymphoma in Africa, a review of epidemiology and etiology,Afr Health Sci 7 166 -75
MobarkNA, 2016.Pediatric non-Hodgkin lymphoma: A retrospective 7-year experience in children and adolescents with nonHodgkin lymphoma treated in King Fahad Medical City (KFMC),Pediat Therapeut 6 60 -5
O'Suoji,C , Welch,JJ , Perkins,SL , Smith,LM , Weitzman,S , Simko,SJ, 2016.Rare pediatric non-Hodgkin lymphomas:,Pediatr Bl Cancer 63 794 -800
GrossTG,TermuhlenAM, 2007.Pediatric non-Hodgkin's lymphoma,Curr Oncol Rep 9 459 -6
PourtsidisA,ServitzoglouM,BakaM,BouhoutsouD,VarvoutsiM,DoganisD, 2015.B-cell non-Hodgkin Lymphoma: 21-year experience with FAB-LMB protocols in a single institute in Greece,Int J Blood Res Disord 2 2 -
SagarTG,RamananSG,SreedahranPS, 2003.Ifosfamide-based intensive mcp-842 protocol in diffuse intermediate and highgrade non-Hodgkin's lymphoma,Indian J Med Paediatr Oncol 24 5 -6
Minard-ColinV,BrugieresL,ReiterA,CairoMS,GrossTG,BurkhardtWB, 2015.Non-Hodgkin lymphoma in children and adolescents: Progress through effective collaboration, current knowledge, and challenges ahead,J Clin Oncol 33 2963 -74
MostertS,AroraRS,ArreolaM,BagaiP,FriedrichP,GuptaS, 2011.Abandonment of treatment for childhood cancer: position statement of a SIOP PODC working group,Lancet Oncol 12 719 -20
MartijnHA,NjugunaF,OlbaraG, 2017.Influence of health insurance status on paediatric non-Hodgkin's lymphoma treatment in Kenya,BMJ Paediatr Open 1 e000149 -
0

Citations

0

Downloads

66

Views